シルデナフィル医薬品の世界市場レポート 2025年

シルデナフィル医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）8.6%で51億3,000万米ドルに成長します。予測期間における成長の原動力は、シルデナフィルジェネリック製剤の受け入れ拡大、先進地域における肺動脈性肺高血圧症の有病率の上昇、費用対効果の高い泌尿器科治療に対する需要の高まり、合併症を伴う世界人口の高齢化です。予測期間中に予想される主な動向としては、一般用医薬品（OTC）の開発、シルデナフィルとデジタル・ヘルス・ソリューションのバンドル、速溶錠や徐放錠などの製剤革新、女性の性機能障害研究への重点化、シルデナフィルの幅広い男性用ウェルネス製品ラインへの統合などが挙げられます。

勃起不全の有病率の増加がシルデナフィル医薬品市場の成長を牽引すると予想されます。勃起不全とは、性行為を行うのに十分な勃起を達成または維持することが、一貫してまたは繰り返し困難になる状態のことです。このような有病率の増加は、肥満、糖尿病、心血管疾患など、血流やホルモンレベルに影響を及ぼす生活習慣に関連した健康問題に起因するところが大きいです。シルデナフィルは、陰茎への血流を促進し、性機能を改善することで作用します。即効性があり、非侵襲的なソリューションであるため、勃起不全に悩む人々の自信と生活の質を高める。例えば、2022年1月、英国のヘルスケア・プロバイダーであるEDクリニックスは、40歳から70歳の男性の約50～55％が勃起不全を経験しており、英国では約430万人の男性が勃起不全を経験していると報告しました。世界の推計では、2025年までに3億2,200万人が罹患すると予測されています。したがって、勃起不全の有病率の増加がシルデナフィル医薬品市場の成長を促進しています。

シルデナフィル医薬品市場の各企業は、ユーザーエクスペリエンスを向上させ、市場リーチを拡大するために、フレーバー付きの急速溶解勃起不全（ED）錠剤など、高度なドラッグデリバリーシステムを備えた革新的な製品の開発に注力しています。これらの錠剤は素早く溶けるように設計されており、従来のED錠剤に代わる控えめで便利な代替品を提供し、より良い口当たりのために香料が加えられています。例えば、2023年8月、米国の健康・ウェルネス企業であるMangoceuticals社は、シルデナフィル配合のED治療薬「Mango」を発売しました。この製剤は、シルデナフィルとオキシトシンやL-アルギニンなどの独自化合物をマンゴー風味の速溶錠に配合したもので、より早く効果が現れ、便利になるように設計されています。また、安全な遠隔医療プラットフォームを通じて配布されるため、診察や処方に簡単にアクセスすることができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界シルデナフィル医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のシルデナフィル医薬品市場：成長率分析
• 世界のシルデナフィル医薬品市場の実績：規模と成長, 2019-2024
• 世界のシルデナフィル医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界シルデナフィル医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のシルデナフィル医薬品市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブランド医薬品
• ジェネリック医薬品
• 市販薬
• 世界のシルデナフィル医薬品市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• 経口懸濁液
• 局所用ジェル
• 注射剤
• 世界のシルデナフィル医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のシルデナフィル医薬品市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 勃起不全治療
• 肺動脈性高血圧症（PAH）の治療
• その他の性機能障害
• 適応外使用
• 世界のシルデナフィル医薬品市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 男性
• 女性
• ヘルスケア従事者
• 世界のシルデナフィル医薬品市場ブランド医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィルムコーティング製剤
• 口腔内崩壊フィルム
• 舌下ストリップ
• チュアブル錠
• 世界のシルデナフィル医薬品市場ジェネリック医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的同等性製剤
• 固定用量配合剤
• シルデナフィルの複合変異体
• 代替塩形態
• 世界のシルデナフィル医薬品市場市販薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブとシルデナフィルのブレンド
• シルデナフィルベースのサプリメント
• 低用量の非処方薬
• 性的ウェルネスコンボパック

第7章 地域別・国別分析

• 世界のシルデナフィル医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のシルデナフィル医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• シルデナフィル医薬品市場：競合情勢
• シルデナフィル医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Macleods Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Aurobindo Pharma Ltd.
• Hikma Pharmaceuticals plc
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Lupin Ltd.
• Zydus Lifesciences
• Hetero Drugs Ltd.
• Glenmark Pharmaceuticals Ltd.
• Alkem Laboratories Ltd.
• Torrent Pharmaceuticals Ltd.
• Jubilant Pharmova Limited
• Ajanta Pharma Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• シルデナフィル医薬品市場2029：新たな機会を提供する国
• シルデナフィル医薬品市場2029：新たな機会を提供するセグメント
• シルデナフィル医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sildenafil is a phosphodiesterase type 5 (PDE5) enzyme inhibitor primarily developed to relax blood vessels and enhance blood flow by amplifying the effects of nitric oxide. It is clinically used to treat erectile dysfunction and pulmonary arterial hypertension by promoting increased blood flow to specific tissues.

The main types of sildenafil drugs include branded drugs, generic drugs, and over-the-counter drugs. Branded sildenafil drugs are prescription medications marketed under a proprietary trade name, developed and patented by pharmaceutical companies. These medications are typically recognized for their guaranteed quality, clinical validation, and broad recognition. Sildenafil is available in various dosage forms, including tablets, oral suspension, topical gel, and injectable. It is distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Sildenafil is used for applications such as treating erectile dysfunction, pulmonary arterial hypertension (PAH), other sexual dysfunctions, and off-label uses. The end users of this drug include men, women, and healthcare professionals.

The sildenafil drug market research report is one of a series of new reports from The Business Research Company that provides sildenafil drug market statistics, including sildenafil drug industry global market size, regional shares, competitors with a sildenafil drug market share, detailed sildenafil drug market segments, market trends and opportunities, and any further data you may need to thrive in the sildenafil drug industry. This sildenafil drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sildenafil drug market size has grown strongly in recent years. It will grow from $3.39 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth observed during the historic period can be attributed to the rising prevalence of erectile dysfunction due to an aging population, increasing awareness and openness about men's sexual health, early marketing efforts aimed at lifestyle enhancement, regulatory approvals for treating pulmonary arterial hypertension, and growth in discretionary spending on wellness drugs.

The sildenafil drug market size is expected to see strong growth in the next few years. It will grow to $5.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The projected growth in the forecast period is driven by the increasing acceptance of generic sildenafil formulations, a rising prevalence of pulmonary arterial hypertension in developed regions, growing demand for cost-effective urology treatments, and the aging global population with associated comorbidities. Key trends expected in the forecast period include the development of over-the-counter (OTC) versions, bundling of sildenafil with digital health solutions, innovations in formulations such as fast-dissolving and extended-release tablets, a stronger focus on female sexual dysfunction research, and the integration of sildenafil into broader men's wellness product lines.

The increasing prevalence of erectile dysfunction is expected to drive the growth of the sildenafil drug market. Erectile dysfunction is a condition where individuals have consistent or recurrent difficulty in achieving or maintaining an erection sufficient for sexual performance. This rise in prevalence is largely attributed to lifestyle-related health issues that affect blood flow and hormone levels, such as obesity, diabetes, and cardiovascular disease. Sildenafil works by enhancing blood flow to the penis, improving sexual function. It offers a fast-acting, non-invasive solution, boosting confidence and quality of life for those affected by erectile dysfunction. For instance, in January 2022, the ED Clinics, a UK-based healthcare provider, reported that about 50-55% of men aged 40 to 70 experience erectile dysfunction, accounting for around 4.3 million men in the UK. Global estimates predict 322 million people will be affected by 2025. Therefore, the increasing prevalence of erectile dysfunction is fueling the growth of the sildenafil drug market.

Companies in the sildenafil drug market are focusing on developing innovative products with advanced drug delivery systems, such as flavored rapid-dissolve erectile dysfunction (ED) tablets, to improve user experience and expand their market reach. These tablets are designed to dissolve quickly, offering a discreet and convenient alternative to traditional ED tablets, with added flavors for better palatability. For example, in August 2023, Mangoceuticals, Inc., a US-based health and wellness company, launched a sildenafil-based ED product called Mango. This formulation combines sildenafil with proprietary compounds such as oxytocin and L-arginine in a mango-flavored, rapid-dissolve tablet, designed for faster onset and convenience. It offers a discreet, user-friendly experience and is distributed through a secure telemedicine platform for easy access to consultations and prescriptions.

In November 2023, Dare Bioscience Inc., a US-based biopharmaceutical company, extended its partnership with Premier Research International LLC to accelerate the clinical development of women's health drugs. This collaboration focuses on improving clinical trials, regulatory support, and the development of therapies for conditions such as female sexual arousal disorder, contraception, and vaginal health. Premier Research International LLC is a US-based contract research organization specializing in clinical development and regulatory support for biotech and pharmaceutical companies.

Major players in the sildenafil drug market are Pfizer Inc., Sanofi S.A., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Zydus Lifesciences, Hetero Drugs Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Jubilant Pharmova Limited, and Ajanta Pharma Ltd.

North America was the largest region in the sildenafil drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sildenafil drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sildenafil drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sildenafil drug market consists of sales of silofast effervescent formulations, sildenafil softgel capsules, sildenafil lozenges, oral thin films with buccal absorption, sildenafil nasal spray, liposomal sildenafil formulations, and sildenafil transdermal patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sildenafil Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sildenafil drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sildenafil drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sildenafil drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Branded Drugs; Generic Drugs; Over The Counter Drugs
• 2) By Dosage Form: Tablets; Oral Suspension; Topical Gel; Injectable
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Erectile Dysfunction Treatment; Pulmonary Arterial Hypertension (PAH) Treatment; Other Sexual Dysfunction; Off-Label Uses
• 5) By End-User: Men; Women; Healthcare Professionals
• Subsegments:
• 1) By Branded Drugs: Film-Coated Formulations; Orodispersible Films; Sublingual Strips; Chewable Tablets
• 2) By Generic Drugs: Bioequivalent Formulations; Fixed-Dose Combinations; Compounded Sildenafil Variants; Alternate Salt Forms
• 3) By Over The Counter Drugs: Herbal-Sildenafil Blends; Sildenafil-Based Supplements; Low-Dose Non-Prescription Formulations; Sexual Wellness Combo Packs
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; GSK plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sildenafil Drug Market Characteristics

3. Sildenafil Drug Market Trends And Strategies

4. Sildenafil Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sildenafil Drug Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sildenafil Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sildenafil Drug Market Growth Rate Analysis
• 5.4. Global Sildenafil Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sildenafil Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sildenafil Drug Total Addressable Market (TAM)

6. Sildenafil Drug Market Segmentation

• 6.1. Global Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded Drugs
• Generic Drugs
• Over The Counter Drugs
• 6.2. Global Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Oral Suspension
• Topical Gel
• Injectable
• 6.3. Global Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Sildenafil Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Erectile Dysfunction Treatment
• Pulmonary Arterial Hypertension (PAH) Treatment
• Other Sexual Dysfunction
• Off-Label Uses
• 6.5. Global Sildenafil Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Men
• Women
• Healthcare Professionals
• 6.6. Global Sildenafil Drug Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Film-Coated Formulations
• Orodispersible Films
• Sublingual Strips
• Chewable Tablets
• 6.7. Global Sildenafil Drug Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioequivalent Formulations
• Fixed-Dose Combinations
• Compounded Sildenafil Variants
• Alternate Salt Forms
• 6.8. Global Sildenafil Drug Market, Sub-Segmentation Of Over The Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal-Sildenafil Blends
• Sildenafil-Based Supplements
• Low-Dose Non-Prescription Formulations
• Sexual Wellness Combo Packs

7. Sildenafil Drug Market Regional And Country Analysis

• 7.1. Global Sildenafil Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sildenafil Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sildenafil Drug Market

• 8.1. Asia-Pacific Sildenafil Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sildenafil Drug Market

• 9.1. China Sildenafil Drug Market Overview
• 9.2. China Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sildenafil Drug Market

• 10.1. India Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sildenafil Drug Market

• 11.1. Japan Sildenafil Drug Market Overview
• 11.2. Japan Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sildenafil Drug Market

• 12.1. Australia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sildenafil Drug Market

• 13.1. Indonesia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sildenafil Drug Market

• 14.1. South Korea Sildenafil Drug Market Overview
• 14.2. South Korea Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sildenafil Drug Market

• 15.1. Western Europe Sildenafil Drug Market Overview
• 15.2. Western Europe Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sildenafil Drug Market

• 16.1. UK Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sildenafil Drug Market

• 17.1. Germany Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sildenafil Drug Market

• 18.1. France Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sildenafil Drug Market

• 19.1. Italy Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sildenafil Drug Market

• 20.1. Spain Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sildenafil Drug Market

• 21.1. Eastern Europe Sildenafil Drug Market Overview
• 21.2. Eastern Europe Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sildenafil Drug Market

• 22.1. Russia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sildenafil Drug Market

• 23.1. North America Sildenafil Drug Market Overview
• 23.2. North America Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sildenafil Drug Market

• 24.1. USA Sildenafil Drug Market Overview
• 24.2. USA Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sildenafil Drug Market

• 25.1. Canada Sildenafil Drug Market Overview
• 25.2. Canada Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sildenafil Drug Market

• 26.1. South America Sildenafil Drug Market Overview
• 26.2. South America Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sildenafil Drug Market

• 27.1. Brazil Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sildenafil Drug Market

• 28.1. Middle East Sildenafil Drug Market Overview
• 28.2. Middle East Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sildenafil Drug Market

• 29.1. Africa Sildenafil Drug Market Overview
• 29.2. Africa Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sildenafil Drug Market Competitive Landscape And Company Profiles

• 30.1. Sildenafil Drug Market Competitive Landscape
• 30.2. Sildenafil Drug Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Sildenafil Drug Market Other Major And Innovative Companies

• 31.1. Macleods Pharmaceuticals Ltd.
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Perrigo Company plc
• 31.4. Aurobindo Pharma Ltd.
• 31.5. Hikma Pharmaceuticals plc
• 31.6. Dr. Reddy's Laboratories Ltd.
• 31.7. Cipla Ltd.
• 31.8. Lupin Ltd.
• 31.9. Zydus Lifesciences
• 31.10. Hetero Drugs Ltd.
• 31.11. Glenmark Pharmaceuticals Ltd.
• 31.12. Alkem Laboratories Ltd.
• 31.13. Torrent Pharmaceuticals Ltd.
• 31.14. Jubilant Pharmova Limited
• 31.15. Ajanta Pharma Ltd.

32. Global Sildenafil Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sildenafil Drug Market

34. Recent Developments In The Sildenafil Drug Market

35. Sildenafil Drug Market High Potential Countries, Segments and Strategies

• 35.1 Sildenafil Drug Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sildenafil Drug Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sildenafil Drug Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer